Press release: Maquet Getinge Group
2017-04-21
Getinge is proud to announce the launch of the Advanta™ V12™ 32mm length* balloon expandable covered stent at Charing Cross International Congress. This is a much needed addition to the Advanta™ V12™ product offering and will allow clinicians additional treatment options for optimal patient outcomes.
With over 200 clinical publications and close to 500,000 patients successfully treated worldwide, this latest product line extension will add to the rapidly growing body of evidence supporting the safety and efficacy of Getinge’s covered stent technology.
The Advanta™ V12™ covered stent is a low profile, pre-mounted balloon expandable covered stent made of a radial expandable 316L stainless steel that is completely encapsulated with a patented one-piece PTFE covering technology. Getinge’s proprietary covering technology creates a microporous PTFE layer that completely encapsulates the stainless steel stent and allows for uniform expansion without ridges or folds in the material being formed. V12 is customizable with the ability to post dilate to meet each patients anatomical needs.
Getinge will also host, at Charing Cross, in partnership with VASCULAR INTERNATIONAL, a series of masterclass workshops in which participants will have hands-on experience using the new Advanta™ V12™ 32mm and learn the latest techniques from the experts. “It is extremely important to provide appropriate training and guidance to the medical community and these workshops allow not only hands-on experience on training models but also provide the participants with the opportunity to network and build relationships with medical experts” says Markus Stirner-Schilling, Vice President, Marketing & Academy, Getinge, Europe, Middle East & Africa.
Getinge will also support two very important satellite symposia with a focus on Advanta™ V12™ and new INTERGARD SYNERGY data.
*32mm lengths not available in all regions
